Oura Appoints Former Apple Health Expert, Expanding Healthcare Ambitions
Oura, the company known for its smart rings designed for health and wellness tracking, has made a significant move by hiring Ricky Bloomfield, a former member of Apple’s health division, as its new Chief Medical Officer. Reported by Mark Gurman in his “Power On” column on Bloomberg, this appointment highlights Oura’s strategy to reinforce its presence in the healthcare and wellness industries.

The Oura Ring 4 in multiple colors.
In his new role, Bloomfield will be instrumental in forming a clinical team at Oura, emphasizing the importance of clinical validation for their health features. He’ll also focus on creating partnerships with healthcare organizations, looking to integrate Oura’s technology into medical and wellness programs. Another critical responsibility for Bloomfield will be navigating regulatory approvals for Oura’s health features to ensure they meet healthcare industry standards.

The Oura Ring 4 in Gold.
Bloomfield’s previous experience at Apple Health offers him an in-depth understanding of consumer technology’s interface with healthcare. While at Apple, he saw the advancement of health tracking in devices like the Apple Watch. This experience gives Bloomfield valuable insights into designing user-friendly yet clinically relevant health tools, a crucial aspect for companies in the wearable tech market. He previously led teams that launched features, including Health Records on iPhone.
According to Bloomfield, the wearables landscape has greatly matured, becoming a mainstream technology. He noticed the growing tendency for users to monitor their health data and share it with their doctors, which underlines the need for accuracy in wearable health technology. His expertise will be extremely valuable to Oura as they aim to enhance their capabilities and build credibility.
Bloomfield aims to improve the connection between patients and healthcare providers at Oura. By obtaining regulatory clearances for their health features, Oura intends to boost its marketing efforts and increase adoption within the medical community. Currently, a lack of approvals can limit claims and how doctors utilize the data. Bloomfield believes Oura’s technology could serve as an early indicator for conditions like hypertension and prediabetes.
This is a strategic hire by Oura. Bringing in a seasoned professional from a major player like Apple demonstrates the company’s commitment to advancing its health offerings and establishing itself as a significant player in digital health.